Containing: Purified Aqua, 25% BRIGHLETTE, 20% Kojic Mushroom Extract, 20% Fision Activewhite, Stabilized 20% OptiMSM, 10% High Potency Organic Jarrah Honey, 3% Licorice Root Extract, 2% Chamomile Extract, Hyaluronic Acid Virgin Cucumber Seed Oil, Zinc Oxide, Organic AMTicide Coconut.
The plausible timeline, reconstructed from Lilly's disclosed trial schedule and standard regulatory review windows, looks roughly like this: Q2-Q3 2026: TRIUMPH-1 and TRIUMPH-2 readouts
Companion Supplies & Routine Support DSIP Dosage Chart This DSIP dosage chart summarizes the IV trial context and SubQ research-planning ranges from 100 mcg to 300 mcg shown in the dosing section above
Medications are evaluated based on several criteria: whether they indicate an underlying disqualifying condition, whether they pose teratogenic risks to potential recipients, whether they affect donor safety during phlebotomy, and whether they compromise plasma product integrity
Using the scDRS munge-gs function, the top 1,000 AD-associated genes from the MAGMA analysis were extracted, and the gene-level statistics were formatted into an scDRS .gs file
